NLS Pharmaceutics Ltd.  ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on developing innovative therapies for central nervous system (CNS) disorders, is pleased to ...

When it comes to sleep apnea, many of the costs you pay aren’t as obvious as the bill you’ll get for treatments. For example, one study found that untreated sleep apnea in the United States ...

How do you know which sleep apnea treatment is right for you? There are a number of ways to treat your symptoms and help you get a restful night’s sleep. Talk with your doctor before you try one.

Sleep disorders are fairly common in older adults, resulting in many getting less sleep than they need. This may be due to reasons including: medications health issues underlying sleep disorders ...

Patient: "I've tried everything, but I still can't sleep." Me: "Yes ... Insomnia is one of the best examples of performance anxiety. Typically, when patients first have symptoms, they have ...

The Food and Drug Administration (FDA) gave the green light to the the first-ever medication for obstructive sleep apnea (OSA). The newly approved drug, Zepbound (tirzepatide), targets adults with ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...

The link between poor sleep and mental health problems could ... vivid and upsetting for individuals suffering from mental health disorders such as depression, anxiety and post-traumatic stress ...

The Food and Drug Administration (FDA) on Dec. 20 approved the obesity medication Zepbound (tirzepatide) as the first pharmaceutical treatment for moderate-to-severe obstructive sleep apnea (OSA) in ...

Abby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she worked in medical writing, ...